Trust research team enrolls first participant in the UK to new Alzheimer's drug trial

Congratulations to Dr. Nilforooshan and the research team for enrolling the first participant in the UK to the CREAD study

FIRST PARTICIPANT ENROLLED IN THE UK!!!

Congratulations to Dr. Nilforooshan and the research team for enrolling the first participant in the UK to the CREAD study which is looking at efficacy and safety of crenezumab in patients with Prodromal-to-mild Alzheimer’s disease. Enrolling first participants in the UK ensures our continued success in raising our profile on a global scale.

 

If you would like to find out more about research at our trust or refer a participant email: research@sabp.nhs.uk